CAM
BVS icon

ClariVest Asset Management’s Bioventus BVS Stock Holding History

ClariVest Asset Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$610 Hold
106
– – ﹤0.01% 742
2024
Q2 		$610 Hold
106
– – ﹤0.01% 742
2024
Q1 		$551 Hold
106
– – ﹤0.01% 779
2023
Q4 		$559 Buy
+106
New +$419 ﹤0.01% 801

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClariVest Asset Management's BVS Position: Q3 2024 in Review

ClariVest Asset Management held its Bioventus (BVS) position steady in Q3 2024 at 106 shares worth $610. The position accounts for ﹤0.01% of the portfolio, ranked #742.

ClariVest Asset Management first reported a position in BVS in Q4 2023 and has held it in 4 quarters since. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • ClariVest Asset Management held 106 shares of Bioventus worth $610 as of Q3 2024.
  • ClariVest Asset Management left its Bioventus share count unchanged in Q3 2024.
  • Bioventus made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #742 holding.
  • ClariVest Asset Management first reported a position in Bioventus in Q4 2023 and has held it in 4 quarters since.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.